CURRENT STOCK PRICE
CURRENT STOCK PRICE
NASDAQ : DOX

$45.90   + 0.10
10/23/14 4:00 p.m. ET
delayed 20 minutes
INVESTOR TOOL KIT

News Release 

 

shareemail  print
Printer Friendly Version View printer-friendly version
<< Back
Download PDF Download PDF
Second Quarter Results for Fiscal 2012

Board of Directors Approves Quarterly Dividend Program of $0.13 per Ordinary Share
Revises Fiscal 2012 Guidance: Raises non-GAAP EPS Growth Outlook, but Reduces Revenue Growth Forecast Due to Changes in the Outlook at AT&T

ST. LOUIS, May 1, 2012 /PRNewswire via COMTEX/ --Key highlights:

  • The Board of Directors has approved a quarterly cash dividend program, subject to shareholder approval, of $0.13 per ordinary share. If the program is approved by shareholders, the Company expects that the first quarterly dividend would be paid in the first quarter of fiscal 2013
  • Revised fiscal 2012 guidance: At least 12-14% non-GAAP EPS growth expected in fiscal 2012, raised from previous expectation of 11-13%. Expected revenue growth of 3-4% on a constant currency basis, lowered from previous expectation of 5-6% due to changes in the outlook at AT&T. Expected reported revenue growth of 2.5-3.5% including the effects of foreign currency fluctuations, revised from previous expectation of 4-5%
  • Second fiscal quarter revenue of $809 million, compared to the $800-$820 million guidance range. Foreign currency movements positively affected revenue by approximately $1 million sequentially relative to the first fiscal quarter of 2012
  • Second fiscal quarter non-GAAP operating income of $134 million; non-GAAP operating margin of 16.6%; GAAP operating income of $110 million
  • Second fiscal quarter diluted non-GAAP EPS of $0.67, compared to the $0.62-$0.68 guidance range, excluding amortization of purchased intangible assets and other acquisition related costs, gain on sale of investment and equity-based compensation expense, net of related tax effects
  • Diluted GAAP EPS of $0.60 for the second fiscal quarter, higher than the $0.50-$0.58 guidance range due to a $0.04 one-time gain resulting from the sale of the Company's remaining investment in Longshine
  • Free cash flow of $53 million for the second fiscal quarter
  • Twelve-month backlog of $2.725 billion at the end of the second fiscal quarter, up $35 million from the end of the first fiscal quarter of 2012
  • Repurchased $117 million of ordinary shares during the second fiscal quarter
  • Third quarter fiscal 2012 guidance: Expected revenue of approximately $805-$825 million and diluted non-GAAP EPS of $0.64-$0.70, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.52-$0.60

Amdocs Limited (NYSE: DOX) today reported that for its second fiscal quarter ended March 31, 2012, revenue was $808.9 million, up 0.2% sequentially from the first fiscal quarter of 2012 and up 2.5% as compared to last year's second fiscal quarter. Net income on a non-GAAP basis was $114.7 million, or $0.67 per diluted share, compared to non-GAAP net income of $110.3 million, or $0.58 per diluted share, in the second quarter of fiscal 2011. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition related costs, gain on sale of investment and equity-based compensation expenses of $12.8 million, net of related tax effects, in the second quarter of fiscal 2012 and excludes such amortization and other acquisition related costs and equity-based compensation expenses of $16.2 million, net of related tax effects, in the second quarter of fiscal 2011. The Company's GAAP net income for the second quarter of fiscal 2012 was $101.9 million, or $0.60 per diluted share, compared to GAAP net income of $94.1 million, or $0.50 per diluted share, in the prior year's second fiscal quarter.

"Our second fiscal quarter performance reflects ongoing deal momentum in the emerging markets and healthy business activity in Europe, partially offset by a slow recovery of spending at AT&T. In the emerging markets, our presence continues to strengthen as we win influential transformation programs in both Southeast Asia and Latin America. We are also seeing our emerging markets customers become increasingly interested in a full managed services business model. In Europe, we continue to gain traction across our portfolio. Our performance in most accounts in North America was consistent with expectations, including the revised contract terms with Bell Canada that became effective at the beginning of the second fiscal quarter. On the other hand, our outlook at AT&T has deteriorated as the customer continues to re-focus its IT priorities, and we now anticipate weakness to persist for the remainder of the fiscal year," said Eli Gelman, chief executive officer of Amdocs Management Limited.

Gelman continued, "As evidence of our growing emerging markets presence, we announced new wins at Globe and CNT today. At Globe in the Philippines, we finalized an agreement to modernize the customer's BSS and Data Warehouse infrastructure, all under a seven-year agreement. At CNT in Ecuador, we will provide an integrated BSS and OSS solution, initially supporting wireline operations - encompassing fixed-line, enterprise, broadband and IPTV lines of business - and with the capability to support wireless services in the future. In Europe, we announced important areas of activity within the Vodafone group today, including a global licensing agreement with the parent company and a BSS modernization in the Netherlands, our first project captured under the global agreement. As our presence in Europe continues to strengthen, Vodafone remains a marquee customer for Amdocs in the region."

Gelman said, "Our outlook for AT&T revenue has weakened for the remainder of the fiscal year and is overshadowing otherwise very solid performance across Amdocs. Factoring in the changes to our forecast at AT&T, we have revised down our fiscal 2012 revenue forecast, but we continue to anticipate sequential growth acceleration in the second half of the fiscal year. Business activity outside of AT&T is ramping at or ahead of plan. Furthermore, due to our stable margin outlook and the contributions from our continued share repurchase activity, we are raising our full year non-GAAP earnings per share outlook to at least 12-14% year-over-year growth from our prior expectations of 11-13% growth. This outlook does not include any future repurchase activity."

Gelman concluded, "Further demonstrating our confidence in Amdocs' future and our commitment to enhancing shareholder value, our Board of Directors has authorized the initiation of a quarterly cash dividend of $0.13 per ordinary share."

Dividend

The Company announced that its Board of Directors has approved, subject to shareholder approval, the institution of a quarterly cash dividend program at the quarterly rate of $0.13 per share. The Company's articles of incorporation require shareholder approval for the payment of dividends, and the Company will call a special shareholders meeting to approve the dividend program to be held on July 31, 2012. The Board has set June 15, 2012, as the record date for determining the shareholders entitled to vote at the meeting. If the program is approved by shareholders, the Company expects that the first quarterly dividend would be paid in the first quarter of fiscal 2013.

Financial Discussion of Second Fiscal Quarter Results

Free cash flow was $53 million for the quarter, comprised of cash flow from operations of $75 million less $22 million in net capital expenditures and other. Second quarter free cash flow results include the payment of annual bonuses for the prior fiscal year.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.725 billion at the end of the second quarter of fiscal 2012.

Financial Outlook

Amdocs expects that revenue for the third quarter of fiscal 2012 will be approximately $805-$825 million. Diluted earnings per share on a non-GAAP basis for the third fiscal quarter are expected to be $0.64-$0.70, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the third fiscal quarter will be $0.52-$0.60.

Conference Call Details

Amdocs will host a conference call on May 1, 2012 at 5:00 p.m. Eastern Time to discuss the Company's second fiscal quarter results. The call will be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other income (expense), net, non-GAAP income taxes, non-GAAP net income, and non-GAAP earnings per share growth. These non-GAAP measures exclude the following items:

  • amortization of purchased intangible assets and other acquisition related costs;
  • gain on sale of investment;
  • equity-based compensation expense; and
  • tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP net income, and non-GAAP earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets and other acquisition related costs, gain on sale of investment, equity-based compensation expense and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these non-cash expenses in reviewing its results and those of its competitors, because the amounts of the expenses between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the expenses.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, interest and other income (expense), net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments.

Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

About Amdocs

For 30 years, Amdocs has ensured service providers' success and embraced their biggest challenges. To win in the connected world, service providers rely on Amdocs to simplify the customer experience, harness the data explosion, stay ahead with new services and improve operational efficiency. The global company uniquely combines a market-leading BSS, OSS and network control product portfolio with value-driven professional services and managed services operations. With revenue of $3.2 billion in fiscal 2011, Amdocs and its over 19,000 employees serve customers in more than 60 countries.

Amdocs: Embrace Challenge, Experience Success.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs ability to grow in the business markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2011 filed on December 8, 2011 and our Form 6-K furnished for the first quarter of fiscal 2012 on February 14, 2012.

AMDOCS LIMITED

Consolidated Statements of Income

(in thousands, except per share data)








Three months ended


Six months ended



March 31,


March 31,



2012


2011


2012


2011








Revenue:









License


$ 26,238


$ 28,695


$ 62,034


$ 58,601

Service


782,690


760,240


1,553,904


1,505,515



808,928


788,935


1,615,938


1,564,116

Operating expenses:









Cost of license


995


198


1,926


898

Cost of service


517,549


513,238


1,033,730


1,021,376

Research and development


60,350


53,536


121,657


108,528

Selling, general and administrative


106,842


99,064


213,179


203,421

Amortization of purchased intangible
assets and other


13,320


16,343


26,526


35,753



699,056


682,379


1,397,018


1,369,976

Operating income


109,872


106,556


218,920


194,140










Interest and other income (expense), net


5,286


49


1,673


(3,068)

Income before income taxes


115,158


106,605


220,593


191,072










Income taxes


13,288


12,495


25,992


23,571

Net income


$ 101,870


$ 94,110


$ 194,601


$ 167,501

Basic earnings per share


$ 0.60


$ 0.50


$ 1.14


$ 0.88

Diluted earnings per share


$ 0.60


$ 0.50


$ 1.13


$ 0.88

Basic weighted average number of shares
outstanding


169,739


187,788


171,231


189,713

Diluted weighted average number of shares
outstanding


170,971


189,232


172,397


191,120

AMDOCS LIMITED

Selected Financial Metrics

(in thousands, except per share data)








Three months ended


Six months ended



March 31,


March 31,



2012


2011


2012


2011










Revenue


$ 808,928


$ 788,935


$ 1,615,938


$ 1,564,116










Non-GAAP operating income


134,312


127,781


267,119


248,049










Non-GAAP net income


114,703


110,321


225,957


210,090










Non-GAAP diluted earnings per
share


$ 0.67


$ 0.58


$ 1.31


$ 1.10










Diluted weighted average number
of shares outstanding


170,971


189,232


172,397


191,120

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)




Three months ended

March 31, 2012



Reconciliation items



GAAP

Amortization of
purchased
intangible
assets and other

Equity based
compensation
expense

Gain on sale
of
investment

Tax effect

Non-GAAP

Operating expenses:







Cost of license

$ 995

$ -

$ -

$ -

$ -

$ 995

Cost of service

517,549

-

(5,763)

-

-

511,786

Research and
development

60,350

-

(1,172)

-

-

59,178

Selling, general and

administrative

106,842

-

(4,185)

-

-

102,657

Amortization of

purchased intangible

assets and other

13,320

(13,320)

-

-

-

-

Total operating expenses

699,056

(13,320)

(11,120)

-

-

674,616








Operating income

109,872

13,320

11,120

-

-

134,312








Interest and other income
(expense), net

5,286

-

-

(6,270)

-

(984)








Income taxes

13,288

-

-

-

5,337

18,625








Net income

$ 101,870

$ 13,320

$ 11,120

$ (6,270)

$ (5,337)

$ 114,703
















Three months ended
March 31, 2011



Reconciliation items



GAAP

Amortization of
purchased intangible
assets and other

Equity based
compensation
expense

Tax effect

Non-GAAP

Operating expenses:






Cost of license

$ 198

$ -

$ -

$ -

$ 198

Cost of service

513,238

-

(1,656)

-

511,582

Research and
development

53,536

-

(317)

-

53,219

Selling, general and

administrative

99,064

-

(2,909)

-

96,155

Amortization of

purchased intangible

assets and other

16,343

(16,343)

-

-

-

Total operating expenses

682,379

(16,343)

(4,882)

-

661,154







Operating income

106,556

16,343

4,882

-

127,781







Income taxes

12,495

-

-

5,014

17,509







Net income

$ 94,110

$ 16,343

$ 4,882

$ (5,014)

$ 110,321













AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)



Six months ended
March 31, 2012



Reconciliation items



GAAP

Amortization of
purchased
intangible
assets and other

Equity based
compensation
expense

Gain on sale
of investment

Tax effect

Non-GAAP

Operating expenses:







Cost of license

$ 1,926

$ -

$ -

$ -

$ -

$ 1,926

Cost of service

1,033,730

-

(11,366)

-

-

1,022,364

Research and
development

121,657

-

(2,213)

-

-

119,444

Selling, general and

administrative

213,179

-

(8,094)

-

-

205,085

Amortization of

purchased intangible

assets and other

26,526

(26,526)

-

-

-

-

Total operating expenses

1,397,018

(26,526)

(21,673)

-

-

1,348,819








Operating income

218,920

26,526

21,673

-

-

267,119








Interest and other income
(expense), net

1,673

-

-

(6,270)

-

(4,597)








Income taxes

25,992

-

-

-

10,573

36,565








Net income

$ 194,601

$ 26,526

$ 21,673

$ (6,270)

$ (10,573)

$ 225,957
























Six months ended
March 31, 2011



Reconciliation items



GAAP

Amortization of
purchased intangible
assets and other

Equity based
compensation
expense

Tax effect

Non-GAAP

Operating expenses:






Cost of license

$ 898

$ -

$ -

$ -

$ 898

Cost of service

1,021,376

-

(6,140)

-

1,015,236

Research and
development

108,528

-

(1,166)

-

107,362

Selling, general and

administrative

203,421

-

(10,850)

-

192,571

Amortization of

purchased intangible

assets and other

35,753

(35,753)

-

-

-

Total operating expenses

1,369,976

(35,753)

(18,156)

-

1,316,067







Operating income

194,140

35,753

18,156

-

248,049







Income taxes

23,571

-

-

11,320

34,891







Net income

$ 167,501

$ 35,753

$ 18,156

$ (11,320)

$ 210,090













AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(in thousands)




As of



March 31,
2012


September 30,
2011






ASSETS










Current assets





Cash, cash equivalents and short-term interest-bearing investments


$ 895,547


$ 1,173,470

Accounts receivable, net, including unbilled of $117,352 and $72,048,
respectively


612,373


565,853

Deferred income taxes and taxes receivable


98,187


112,656

Prepaid expenses and other current assets


145,468


127,341

Total current assets


1,751,575


1,979,320






Equipment and leasehold improvements, net


247,353


258,402

Goodwill and other intangible assets, net


1,909,098


1,933,154

Other noncurrent assets


492,501


465,696

Total assets


$ 4,400,527


$ 4,636,572






LIABILITIES AND SHAREHOLDERS' EQUITY










Current liabilities





Accounts payable, accruals and other


$ 598,266


$ 594,603

Short-term financing arrangements


-


250,000

Deferred revenue


137,029


151,423

Deferred income taxes and taxes payable


26,206


15,180

Total current liabilities


761,501


1,011,206






Other noncurrent liabilities


599,834


602,065

Shareholders' equity


3,039,192


3,023,301

Total liabilities and shareholders' equity


$ 4,400,527


$ 4,636,572

AMDOCS LIMITED

Consolidated Statements of Cash Flows

(in thousands)






Six months ended March 31,



2012


2011






Cash Flow from Operating Activities:





Net income


$ 194,601


$ 167,501

Reconciliation of net income to net cash provided by operating activities:





Depreciation and amortization


79,873


94,049

Equity-based compensation expense


21,673


18,156

Deferred income taxes


(8,283)


12,756

Excess tax benefit from equity-based compensation


(127)


(152)

Gain on sale of investment


(6,270)


-

Loss from short-term interest-bearing investments


895


1,577

Net changes in operating assets and liabilities, net of amounts acquired:





Accounts receivable


(36,831)


20,879

Prepaid expenses and other current assets


(18,626)


(25,225)

Other noncurrent assets


(1,299)


(34,739)

Accounts payable, accrued expenses and accrued personnel


8,972


(69,103)

Deferred revenue


(27,129)


34,293

Income taxes payable


13,888


(1,085)

Other noncurrent liabilities


3,145


18,939

Net cash provided by operating activities


224,482


237,846






Cash Flow from Investing Activities:





Payments for purchase of equipment and leasehold improvements, net


(50,204)


(55,456)

Proceeds from sale of short-term interest-bearing investments


210,703


314,857

Purchase of short-term interest-bearing investments


(192,857)


(263,191)

Cash received from sale of investment


6,270


-

Other


(4,429)


(17,618)

Net cash used in investing activities


(30,517)


(21,408)






Cash Flow from Financing Activities:





Payments under financing arrangements


(250,000)


(200,000)

Repurchase of shares


(256,545)


(274,674)

Proceeds from employee stock options exercised


53,715


35,096

Payments under capital lease, short-term financing arrangements and other


(248)


(443)

Net cash used in financing activities


(453,078)


(440,021)






Net decrease in cash and cash equivalents


(259,113)


(223,583)

Cash and cash equivalents at beginning of period


831,371


1,036,195

Cash and cash equivalents at end of period


$ 572,258


$ 812,612






AMDOCS LIMITED

Supplementary Information

(in millions)






Three months ended



March 31,
2012


December 31,
2011


September 30,
2011


June 30,
2011


March 31,
2011

North America


$ 563.2


$ 573.8


$ 585.1


$ 584.9


$ 598.4

Europe


111.8


110.3


102.0


105.5


97.2

Rest of World


133.9


122.9


125.1


111.0


93.3

Total Revenue


$ 808.9


$ 807.0


$ 812.2


$ 801.4


$ 788.9






Three months ended



March 31,
2012


December 31,
2011


September 30,
2011


June 30,
2011


March 31,
2011

Emerging Markets Revenue


$ 89.4


$ 82.5


$ 79.5


$ 73.2


$ 52.1














Three months ended



March 31,
2012


December 31,
2011


September 30,
2011


June 30,
2011


March 31,
2011

Managed Services Revenue


$ 414.4


$ 419.7


$ 384.8


$ 384.2


$ 382.6














Three months ended



March 31,
2012


December 31,
2011


September 30,
2011


June 30,
2011


March 31,
2011

Customer Experience Systems


$ 758.9


$ 758.0


$ 764.6


$ 751.1


$ 737.2

Directory


50.0


49.0


47.6


50.3


51.7

Total Revenue


$ 808.9


$ 807.0


$ 812.2


$ 801.4


$ 788.9









As of




March 31,
2012


December 31,
2011


September 30,
2011


June 30,
2011


March 31,
2011


12-Month Backlog


$ 2,725


$ 2,690


$ 2,670


$ 2,620


$ 2,590


SOURCE Amdocs

© 2014 Amdocs Inc. All rights reserved.  Site Map  //  Privacy Policy  //  Terms of Use  //